Understanding the seed to patient journey

How does a plant become a medicine? It’s a process.  And it’s a complicated one, which is one of the reasons why natural medicines can vary considerably depending on how they are produced.

Flordis adheres to a strict ‘quality first’ approach to ingredient sourcing and manufacturing processes to help ensure that our products are best-in-class and supported by product specific clinical evidence.

That’s why careful attention is applied to plant species and growing methods through to cultivation and harvest, using precise processes to help produce consistent crops.  This continues, with extracting and manufacturing of specific ingredients following a series of strict controls to help deliver a consistent medicine from one batch to the next.

It is this specific medicine that is tested in clinical trials and it’s the same medicine that you receive.  This consistency means that you can be more confident that you may enjoy the same health benefits identified in clinical research.

At Flordis, this rigorous end-to-end process is what we like to call the ‘seed to patient journey’ – where all of the steps involved in the growth and manufacture of the natural medicine are tightly controlled to reduce variability and to help ensure consistency.

At Flordis, this rigorous end-to-end process is what we like to call the ‘seed to patient journey’, where all of the steps involved in the growth and manufacture of the natural medicine are tightly controlled to reduce variability and to help ensure consistency.

The Flordis seed to patient journey:

1. Consistent raw materials

Wherever possible our cultivation methods observe Good Agricultural Practices (GAP) which involves working closely with farmers and other partners. There is more to the seed-to-patient process, however, including selection of the exact species and standardisation of propagation, cultivation and harvesting. These controls play a large part  in contributing to raw materials with a consistent phytochemical profile.

2. Consistent extraction and manufacture of finished product

The seed-to-patient process demands more than the observation of Good Manufacturing Practice (GMP). Standardisation of all inputs and processes is essential to help ensure product consistency from one batch to the next, often referred to as batch to batch consistency. A series of strict controls are applied to manufacturing processes including solvents used and extraction methods, through to packaging, storage and transportation of finished goods.

3. Clinical research

The final stage in the seed-to-patient process is to conduct research and clinical trials to substantiate safety and efficacy of finished products. Clinical study results are validated by publication in respected peer-reviewed scientific journals. Our batch to batch consistency means that the specific medicine tested in clinical trials is the same medicine used in Flordis products.

 

By applying this high standard, Flordis delivers a specialised portfolio of world class natural medicines that are well tolerated and effective.  The result is more reliable health outcomes. This is one of the reasons why Flordis natural medicines are recommended to millions of people worldwide – and why you can feel confident that you are taking a quality natural medicine.

More from Flordis

Gincosan

Supports memory, cognitive function & mental fatigue
Learn more

KeenMind

Supports memory retention, cognitive function and calm focus
Learn more